share_log

广东康华医疗股份有限公司(3689.HK)新股申购

長雄證券 ·  Oct 28, 2016 00:00  · Researches

  The business summary is based on the Frost & Sullivan report. According to the number of registered hospital beds as of December 31, 2015, Kanghua Hospital operated by Kanghua Medical is the largest private for-profit general hospital in China. In terms of revenue, it is the third largest private for-profit complex hospital in China. Kanghua Hospital is also the first private for-profit general hospital in China to receive a grade 3 A rating under the National Health Planning Commission's classification system (the highest rating a Chinese hospital can obtain). In addition to Hong Wah Hospital, the Group also operates Renkang Hospital, which has not only applied for evaluation under the National Health Planning Commission's classification system. Both hospitals are located in Dongguan, Guangdong Province, and complement each other through patient referrals, technical support, multi-point practice and research, and teaching cooperation. In June 2016, the Group also agreed on the management of the People's Union Cardiovascular Hospital. The development center's vascular disease specialist hospital is located in Chongqing. It is the group's first managed hospital and the first base outside of Guangdong Province. Competitive advantage A multi-disciplinary team of medical professionals and advanced medical facilities belonging to the largest private for-profit integrated hospital in China provides a range of medical services. It has a strong track record in operating China's first Class III private for-profit integrated hospital. It helps future management arrangements and selective mergers and acquisitions have a senior management team with senior management and a stable composition of senior management teams and medical professionals Risk factors. Changes in health care reform policies may have a significant adverse impact on the group's business prices Referral limits under regulatory control and social security plans may affect some medical services And the pricing revenue of the product depends too much on the use of the proceeds obtained through the Group's operations in Guangdong Province, about 9% is used to expand and increase the current healthcare services of Kanghua Hospital and Renkang Hospital, about 36% is used to expand the Group's operating capacity and multidisciplinary professional treatment and diagnosis capabilities, about 10% is used for the consulting and management operations of Extended Group Hospitals, and 35% is used for the expansion of healthcare services in China and 10% for general operating capital

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment